Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Journal of Diagnostic Techniques and Biomedical AnalysisISSN: 2469-5653
Srirupa Das Author
Subjects of specialization
Affiliation
SARS-CoV-2; COVID-19; Real-time PCR; Centers, for Disease Control and Prevention (CDC); Diagnostic assay
Department of Pathology Research, Nuvance Health, Danbury, CT 06810, USA
Biography
Srirupa Das hard-working and independent research scientist with 11+ years of experience in life science and transnational medical/cancer research. Experienced in genomics, diagnostic assay development, infectious diseases and cancer biology. Extensive experience in molecular & cellular biology with the aptitude to adapt these techniques to study any system.
Publications
Research Article Open Access
In-house Modification and Improvement of the CDC Realtime PCR Diagnostic Assay for SARS-CoV-2 Detection
Author(s): Srirupa Das, Candice Dowell-Martino, Lisa Arrigo, Paul N.Fiedler and Sandra Lobo
Objective: The world is currently facing an unprecedented pandemic caused by the novel coronavirus SARS-CoV-2 (COVID-19) which was first reported in late 2019 by China to the World Health Organization (WHO). The containment strategy for COVID-19, which has non-specific flu-like symptoms and where upwards of 80% of the affected has either mild or no symptoms, is critically centered upon diagnostic testing, tracking and isolation. Thus, the development of specific and sensitive diagnostic tests for COVID-19 is key towards the first successful step of disease management.
Methods: Public health organizations like the WHO and the US-based Centers for Disease Control and Prevention (CDC) have developed real-time PCR (RT-PCR) based diagnostic
tests to aid in t... view more»
Social Media
Google Scholars / Researchers Sites
